Literature DB >> 22034586

Increased cerebral oxygen metabolism and ischemic stress in subjects with metabolic syndrome-associated risk factors: preliminary observations.

Ken Uchino1, Ridwan Lin, Syed F Zaidi, Hiroto Kuwabara, Donald Sashin, Nicholas Bircher, Yue-Fang Chang, Maxim D Hammer, Vivek Reddy, Tudor G Jovin, Nirav Vora, Mouhammad Jumaa, Lori Massaro, Julia Billigen, Fernando Boada, Howard Yonas, Edwin M Nemoto.   

Abstract

Hypertension, diabetes, obesity, and dyslipidemia are risk factors that characterize metabolic syndrome (MetS), which increases the risk for stroke by 40%. In a preliminary study, our aim was to evaluate cerebrovascular reactivity and oxygen metabolism in subjects free of vascular disease but with one or more of these risk factors. Volunteers (n=15) 59±15 (mean±SD)years of age clear of cerebrovascular disease by magnetic resonance angiography but with one or more risk factors were studied by quantitative positron emission tomography for measure ment of cerebral blood flow, oxygen consumption, oxygen extraction fraction (OEF), and acetazolamide cerebrovascular reactivity. Eight of ten subjects with MetS risk factors had OEF >50%. None of the five without risk factors had OEF >50%. The presence of MetS risk factors was highly correlated with OEF >50% by Fisher's exact test (p<0.007). The increase in OEF was significantly (P<0.001) correlated with cerebral metabolic rate for oxygen. Increased OEF was not associated with compromised acetazolamide cerebrovascular reactivity. Subjects with one or more MetS risk factors are characterized by increased cerebral oxygen consumption and ischemic stress, which may be related to increased risk of cerebrovascular disease and stroke.

Entities:  

Year:  2010        PMID: 22034586      PMCID: PMC3201728          DOI: 10.1007/s12975-010-0028-2

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  37 in total

Review 1.  Mediators of sympathetic activation in metabolic syndrome obesity.

Authors:  Nora E Straznicky; Nina Eikelis; Elisabeth A Lambert; Murray D Esler
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

2.  Cerebral [15O]water clearance in humans determined by PET: I. Theory and normal values.

Authors:  S Ohta; E Meyer; H Fujita; D C Reutens; A Evans; A Gjedde
Journal:  J Cereb Blood Flow Metab       Date:  1996-09       Impact factor: 6.200

Review 3.  Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications.

Authors:  N Abate
Journal:  J Diabetes Complications       Date:  2000 May-Jun       Impact factor: 2.852

4.  Chronic leptin infusion increases arterial pressure.

Authors:  E W Shek; M W Brands; J E Hall
Journal:  Hypertension       Date:  1998-01       Impact factor: 10.190

5.  Significant association between leukoaraiosis and metabolic syndrome in healthy subjects.

Authors:  K Park; N Yasuda; S Toyonaga; S M Yamada; H Nakabayashi; M Nakasato; T Nakagomi; E Tsubosaki; K Shimizu
Journal:  Neurology       Date:  2007-05-30       Impact factor: 9.910

6.  Metabolic syndrome and the risk of stroke in middle-aged men.

Authors:  Sudhir Kurl; Jari A Laukkanen; Leo Niskanen; David Laaksonen; Juhani Sivenius; Kristiina Nyyssönen; Jukka T Salonen
Journal:  Stroke       Date:  2006-02-09       Impact factor: 7.914

7.  Leptin-receptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic nerve activation in a Caucasian male population.

Authors:  Kazuko Masuo; Nora E Straznicky; Gavin W Lambert; Tomohiro Katsuya; Ken Sugimoto; Hiromi Rakugi; Florentia Socratous; Jacqueline Hastings; Elisabeth A Lambert; Toshio Ogihara; Murray D Esler
Journal:  Hypertens Res       Date:  2008-06       Impact factor: 3.872

8.  Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion.

Authors:  R L Grubb; C P Derdeyn; S M Fritsch; D A Carpenter; K D Yundt; T O Videen; E L Spitznagel; W J Powers
Journal:  JAMA       Date:  1998 Sep 23-30       Impact factor: 56.272

9.  Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation.

Authors:  Moo Yeol Lee; Alejandra San Martin; Puja K Mehta; Anna E Dikalova; Abel Martin Garrido; S Raju Datla; Erin Lyons; Karl-Heinz Krause; Botond Banfi; J David Lambeth; Bernard Lassègue; Kathy K Griendling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-01-15       Impact factor: 8.311

10.  Angiotensin II attenuates functional hyperemia in the mouse somatosensory cortex.

Authors:  Ken Kazama; Gang Wang; Kelly Frys; Josef Anrather; Costantino Iadecola
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-08-07       Impact factor: 4.733

View more
  4 in total

1.  Dynamic Cerebrovascular and Intracranial Pressure Reactivity Assessment of Impaired Cerebrovascular Autoregulation in Intracranial Hypertension.

Authors:  Denis E Bragin; Gloria Statom; Edwin M Nemoto
Journal:  Acta Neurochir Suppl       Date:  2016

2.  Test-retest reproducibility of a rapid method to measure brain oxygen metabolism.

Authors:  Peiying Liu; Feng Xu; Hanzhang Lu
Journal:  Magn Reson Med       Date:  2012-04-19       Impact factor: 4.668

3.  Vessel-specific quantification of blood oxygenation with T2-relaxation-under-phase-contrast MRI.

Authors:  Lisa C Krishnamurthy; Peiying Liu; Yulin Ge; Hanzhang Lu
Journal:  Magn Reson Med       Date:  2014-03       Impact factor: 4.668

4.  Relationship of obesity and insulin resistance with the cerebrovascular reactivity: a case control study.

Authors:  Marcela Rodríguez-Flores; Eduardo García-García; Claudia Vanessa Cano-Nigenda; Carlos Cantú-Brito
Journal:  Cardiovasc Diabetol       Date:  2014-01-03       Impact factor: 9.951

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.